LifeMD(LFMD) - 2023 Q3 - Earnings Call Presentation
LifeMD(LFMD)2023-11-08 23:51
Rapid growth in profitability after achieving adjusted EBITDA profit in Q4 '22 Annual consolidated adjusted EBITDA ($ millions) $10-$11M 2022A $(15)M ($38)M 2023E 2021A Note: Consolidated adjusted EBITDA includes Telehealth and WorkSimpli results. 16 Rapidly expanding gross margins and increasing leverage on marketing spend driving continued growth in profitability 82% 83% 84% 85% 86% 87% 88% 89% 90% Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 20223 Q3 2023 Net Revenue ($ Millions) 72% 55% 62% 50% 54% 51% 0% 25% 50% ...